Multicentre Randomised Controlled Trial to Compare the Clinical & Cost-Effectiveness of a 'Vein Bypass First' with an 'Best Endovascular First' Revascularisation Strategy for Severe Limb Ischaemia due to Infrageniculate Arterial Disease - O

Grant, Margaret (Co-Investigator)
Deeks, Jon (Co-Investigator)
Bradbury, Andrew (Principal Investigator)
Roberts, Tracy (Co-Investigator)
Patel, Smitaa (Co-Investigator)

Short title	Multicentre Randomised Controlled Trial to Compare the Clinical & Cost-Effectiveness of a 'Vein Bypass First' with an 'Best Endovascular First' Revascularisation Strategy for Severe Limb Ischaemia due to Infrageniculate Arterial Disease - O
Status	Finished
Effective start/end date	1/02/14 → 30/04/25

Funding

NIHR

A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial
BASIL-2 Trial Investigators, 27 May 2023, In: The Lancet. 401, 10390, p. 1798-1809
Research output: Contribution to journal › Article › peer-review

Open Access
File
105 Downloads (Pure)